Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 2
1974 4
1976 3
1977 2
1979 1
1980 1
1981 3
1982 3
1983 3
1984 8
1985 2
1986 3
1987 2
1988 1
1989 4
1990 4
1991 3
1992 2
1993 2
1996 2
1997 1
1998 1
1999 2
2000 1
2001 4
2002 2
2003 4
2004 9
2005 5
2006 5
2007 3
2008 7
2009 6
2010 4
2011 3
2012 5
2013 11
2014 3
2015 3
2016 2
2017 4
2018 8
2019 8
2020 5
2021 6
2022 7
2023 8
2024 14
2025 11
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

200 results

Results by year

Filters applied: . Clear all
Page 1
Behavioral interventions for migraine prevention: A systematic review and meta-analysis.
Treadwell JR, Tsou AY, Rouse B, Ivlev I, Fricke J, Buse DC, Powers SW, Minen M, Szperka CL, Mull NK. Treadwell JR, et al. Headache. 2025 Apr;65(4):668-694. doi: 10.1111/head.14914. Epub 2025 Feb 19. Headache. 2025. PMID: 39968795 Free PMC article.
OBJECTIVES/BACKGROUND: This study was undertaken to synthesize evidence on the benefits and harms of behavioral interventions for migraine prevention in children and adults. The efficacy and safety of behavioral interventions for migraine prevention ha …
OBJECTIVES/BACKGROUND: This study was undertaken to synthesize evidence on the benefits and harms of behavioral interventions for migrain …
Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.
Oskoui M, Pringsheim T, Billinghurst L, Potrebic S, Gersz EM, Gloss D, Holler-Managan Y, Leininger E, Licking N, Mack K, Powers SW, Sowell M, Victorio MC, Yonker M, Zanitsch H, Hershey AD. Oskoui M, et al. Neurology. 2019 Sep 10;93(11):500-509. doi: 10.1212/WNL.0000000000008105. Epub 2019 Aug 14. Neurology. 2019. PMID: 31413170 Free PMC article. Review.
RECOMMENDATIONS: The majority of randomized controlled trials studying the efficacy of preventive medications for pediatric migraine fail to demonstrate superiority to placebo. Recommendations for the prevention of migraine in children include c …
RECOMMENDATIONS: The majority of randomized controlled trials studying the efficacy of preventive medications for pediatric …
The effect of blood pressure lowering medications on the prevention of episodic migraine: A systematic review and meta-analysis.
Carcel C, Haghdoost F, Shen J, Nanda P, Bai Y, Atkins E, Torii-Yoshimura T, Clough AJ, Davies L, Cordato D, Griffiths LR, Balicki G, Wang X, Vidyasagar K, Malavera A, Anderson CS, Zagami AS, Delcourt C, Rodgers A. Carcel C, et al. Cephalalgia. 2023 Jun;43(6):3331024231183166. doi: 10.1177/03331024231183166. Cephalalgia. 2023. PMID: 37350141 Free article.
BACKGROUND: Currently, only a few specific blood pressure-lowering medications are recommended for migraine prevention. Whether benefits extend to other classes or drugs is uncertain. METHODS: Embase, MEDLINE, and the Cochrane Central Registry of Controlled Trial …
BACKGROUND: Currently, only a few specific blood pressure-lowering medications are recommended for migraine prevention. Whethe …
Comparison of the Efficacy of Propranolol Versus Valsartan in the Prevention of Migraine: A Randomized Controlled Trial.
Mosarrezaii A, Tahazadeh D, Soleimantabar H, Panahi P. Mosarrezaii A, et al. Pain Manag Nurs. 2025 Feb;26(1):e31-e35. doi: 10.1016/j.pmn.2024.07.001. Epub 2024 Aug 13. Pain Manag Nurs. 2025. PMID: 39142916 Clinical Trial.
Since valsartan is an antihypertensive drug, it is hypothesized that taking valsartan can prevent migraine attacks in patients with the condition. This study aimed to determine the efficacy of propranolol versus valsartan in preventing migraine …
Since valsartan is an antihypertensive drug, it is hypothesized that taking valsartan can prevent migraine attacks in patients …
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention - part 4: propranolol.
Versijpt J, Deligianni C, Hussain M, Amin F, Reuter U, Sanchez-Del-Rio M, Uluduz D, Boucherie D, Zeraatkar D, MaassenVanDenBrink A, Sacco S, Lampl C, Gil-Gouveia R. Versijpt J, et al. J Headache Pain. 2024 Jul 24;25(1):119. doi: 10.1186/s10194-024-01826-y. J Headache Pain. 2024. PMID: 39044170 Free PMC article.
OBJECTIVE: The aim of this paper is to critically re-appraise the published trials assessing propranolol for migraine prophylaxis. METHODS: We report methods and results following the Preferred Reporting Items for Systematic Reviews (PRISMA), by searching MED …
OBJECTIVE: The aim of this paper is to critically re-appraise the published trials assessing propranolol for migraine p …
Combining treatments for migraine prophylaxis: the state-of-the-art.
Pellesi L, Garcia-Azorin D, Rubio-Beltrán E, Ha WS, Messina R, Ornello R, Petrusic I, Raffaelli B, Labastida-Ramirez A, Ruscheweyh R, Tana C, Vuralli D, Waliszewska-Prosół M, Wang W, Wells-Gatnik W. Pellesi L, et al. J Headache Pain. 2024 Dec 5;25(1):214. doi: 10.1186/s10194-024-01925-w. J Headache Pain. 2024. PMID: 39639191 Free PMC article. Review.
Combination treatments for migraine prophylaxis present a promising approach to addressing the diverse and complex mechanisms underlying migraine. ...Further large-scale trials are needed to establish safe and effective combination protocols and solidify thei …
Combination treatments for migraine prophylaxis present a promising approach to addressing the diverse and complex mechanisms underly …
Blood pressure lowering for prevention of episodic migraine: results of a pilot randomized, placebo-controlled trial of combination blood pressure lowering medication with propranolol.
Carcel C, Haghdoost F, Davies L, Cordato D, Griffiths L, Balicki G, Li Q, Freed R, Anderson CS, Zagami AS, Delcourt C, Rodgers A. Carcel C, et al. Front Neurol. 2025 Sep 16;16:1630732. doi: 10.3389/fneur.2025.1630732. eCollection 2025. Front Neurol. 2025. PMID: 41036277 Free PMC article.
CONCLUSION: As a pilot study, the trial was not powered to detect efficacy; larger trials are required to determine the effect of low-dose triple combination blood pressure lowering on migraine. ...CLINICAL TRIAL REGISTRATION: ACTRN1261600093741 …
CONCLUSION: As a pilot study, the trial was not powered to detect efficacy; larger trials are required to determine the effect …
Behavioral Interventions for Migraine Prevention.
Treadwell JR, Tsou AY, Rouse B, Ivlev I, Fricke J, Buse D, Powers SW, Minen M, Szperka CL, Mull NK. Treadwell JR, et al. Rockville (MD): Agency for Healthcare Research and Quality (US); 2024 Sep. Report No.: AHRQ 24-EHC015Report No.: PCORI® 2024-SR-01. Rockville (MD): Agency for Healthcare Research and Quality (US); 2024 Sep. Report No.: AHRQ 24-EHC015Report No.: PCORI® 2024-SR-01. PMID: 39471258 Free Books & Documents. Review.
We also found that mindfulness-based therapy may improve migraine disability more than education, and relaxation + education may improve migraine-related quality of life more than propranolol (SOE: low). ...CONCLUSION: Several behavioral interventions appear …
We also found that mindfulness-based therapy may improve migraine disability more than education, and relaxation + education may impr …
Low-Dose Propranolol versus Amitriptyline for Episodic Migraine Prophylaxis: A Randomized Controlled Trial Assessing Efficacy, Safety, and Cost-Effectiveness.
Roy V, Banu N, Meshram GG, Chowdhury D. Roy V, et al. Clin Drug Investig. 2025 Oct;45(10):781-791. doi: 10.1007/s40261-025-01481-4. Epub 2025 Sep 11. Clin Drug Investig. 2025. PMID: 40932597 Clinical Trial.
BACKGROUND AND OBJECTIVES: Direct head-to-head evidence of propranolol and amitriptyline for migraine prophylaxis is limited. This clinical trial compared the efficacy, safety, and cost-effectiveness of low-dose propranolol versus amitriptyline …
BACKGROUND AND OBJECTIVES: Direct head-to-head evidence of propranolol and amitriptyline for migraine prophylaxis is limited. …
Lacosamide Versus Propranolol in Episodic Migraine, a Randomized Controlled Double-blinded Trial.
Zeinhom MG, Rezk SG, Mohamed AM, Ahmed SR. Zeinhom MG, et al. Mol Neurobiol. 2026 Mar 21;63(1):512. doi: 10.1007/s12035-026-05756-5. Mol Neurobiol. 2026. PMID: 41863672 Free PMC article. Clinical Trial.
Although migraine is the second most prevalent form of headache, its preventive treatment has some contraindications and complications. It has been postulated that lacosamide might inhibit CGRP release in the trigeminal system, which could contribute to migraine …
Although migraine is the second most prevalent form of headache, its preventive treatment has some contraindications and compl …
200 results